Germany · Delayed Price · Currency is EUR Theralase Technologies Statistics
Total Valuation
FRA:TTX has a market cap or net worth of EUR 24.60 million. The enterprise value is 24.74 million.
| Market Cap | 24.60M |
| Enterprise Value | 24.74M |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 257.06M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +8.39% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 7.08% |
| Owned by Institutions (%) | 0.17% |
| Float | 238.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 40.15 |
| PB Ratio | 36.79 |
| P/TBV Ratio | 36.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.29 |
| EV / Sales | 40.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.48 |
Financial Position
The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.29.
| Current Ratio | 0.83 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -230.36 |
Financial Efficiency
Return on equity (ROE) is -269.41% and return on invested capital (ROIC) is -142.42%.
| Return on Equity (ROE) | -269.41% |
| Return on Assets (ROA) | -88.50% |
| Return on Invested Capital (ROIC) | -142.42% |
| Return on Capital Employed (ROCE) | -365.64% |
| Revenue Per Employee | 30,626 |
| Profits Per Employee | -133,187 |
| Employee Count | 20 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 0.82 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.24% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -29.24% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 34.85 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:TTX had revenue of EUR 612,517 and -2.66 million in losses. Loss per share was -0.01.
| Revenue | 612,517 |
| Gross Profit | 338,994 |
| Operating Income | -2.70M |
| Pretax Income | -2.66M |
| Net Income | -2.66M |
| EBITDA | -2.60M |
| EBIT | -2.70M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 49,555 in cash and 195,635 in debt, giving a net cash position of -146,080.
| Cash & Cash Equivalents | 49,555 |
| Total Debt | 195,635 |
| Net Cash | -146,080 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 668,624 |
| Book Value Per Share | 0.00 |
| Working Capital | -182,973 |
Cash Flow
In the last 12 months, operating cash flow was -1.54 million and capital expenditures -59,897, giving a free cash flow of -1.60 million.
| Operating Cash Flow | -1.54M |
| Capital Expenditures | -59,897 |
| Free Cash Flow | -1.60M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 55.34% |
| Operating Margin | -440.39% |
| Pretax Margin | -434.88% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:TTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.39% |
| Shareholder Yield | -8.39% |
| Earnings Yield | -10.83% |
| FCF Yield | -6.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:TTX has an Altman Z-Score of -19.99 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.99 |
| Piotroski F-Score | 3 |